Use of hydroxypregnenolone derivatives for enhancing health and physical performance
申请人:Marchewitz Eric D.
公开号:US20130281418A1
公开(公告)日:2013-10-24
A method for the use of derivatives of hydroxypregnenolone (3-beta,17-alpha-dihydroxypregn-5-en-3-one) to enhance health and physical performance in humans and more particularly to the use of hydroxypregnenolone derivatives for restoring renal hormonal balance, decreasing body weight, reducing adipose tissue, increasing endurance, promoting skeletal muscle growth, boosting androgen levels, inhibiting aromatase, and increasing cognitive function.